Armata Pharmaceuticals, Inc.
AMEX:ARMP · New York Stock Exchange American
-$0.02 today
Vol 0.02M · Avg 0.07M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+284.78%
Period High
$14.80
Period Low
$1.84
Latest
$7.08
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
SELLAS Life Sciences Group, Inc.
NASDAQ:SLS
$1.18B
Genfit S.A.
GNFT
$445.68M
Nuvectis Pharma, Inc.
NASDAQ:NVCT
$341.67M
C4 Therapeutics, Inc.
NASDAQ:CCCC
$331.72M
OmniAb, Inc.
NASDAQ:OABI
$260.36M
Codexis, Inc.
NASDAQ:CDXS
$225.88M
Innate Pharma S.A.
NASDAQ:IPHA
$169.96M
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX
$145.08M
Neonc Technologies Holdings, Inc.
NASDAQ:NTHI
$99.18M
Sangamo Therapeutics, Inc.
NASDAQ:SGMO
$71.28M
What is the latest ARMP filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does ARMP have?
Intrinsic Alpha currently shows 20 recent filings for ARMP.
Explore More
Continue the stock analysis
Jump to another research area for this company.